Filing Details
- Accession Number:
- 0001415889-24-005093
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-23 17:30:04
- Reporting Period:
- 2024-02-06
- Accepted Time:
- 2024-02-23 17:30:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1726445 | Seer Inc. | SEER | Laboratory Analytical Instruments (3826) | 821153150 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1834217 | R. David Horn | C/O Seer, Inc. 3800 Bridge Parkway, Suite 102 Redwood City CA 94065 | President & Cfo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2024-02-06 | 165,038 | $0.00 | 493,195 | No | 4 | A | Direct | |
Class A Common Stock | Disposition | 2024-02-22 | 12,684 | $1.58 | 480,511 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2024-02-06 | 142,557 | $0.00 | 142,557 | $1.77 |
Class A Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2024-02-06 | 140,000 | $0.00 | 140,000 | $1.77 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
142,557 | 2034-02-06 | No | 4 | A | Direct | |
140,000 | 2034-02-06 | No | 4 | A | Direct |
Footnotes
- The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on February 15, 2025.
- The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of RSUs.
- One-fourth of the shares subject to the option vest on February 6, 2025 and 1/48th of the shares vest monthly thereafter.
- The option is subject to vesting requirements based upon achievement of specified performance-based criteria (the "Stock Price Hurdle") which requires that the Issuer achieve a stock price equal to or greater than 200% of the option exercise price during the period beginning on the grant date and ending on February 6, 2031 (the "Performance Period"). If the Stock Price Hurdle is achieved within the Performance Period, then one-fourth of the shares subject to the option vest on the date that achievement of the Stock Price Hurdle is certified and the remaining shares vest annually thereafter in three equal installments.